Recap: Neoleukin Therapeutics Q2 Earnings
Neoleukin Therapeutics (NASDAQ:NLTX) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Uncategorized
Dave & Buster’s Entertainment Shares See Volume; William Blair Upgrades To Outperform
Related Posts
Barclays Initiates Coverage On Victoria’s Secret with Overweight Rating, Announces Price Target of $100
Barclays analyst Adrienne Yih initiates coverage on Victoria's Secret (NYSE:VSCO) with a Overweight rating and announces Price Target of $100.
Nicolet Bankshares: Q2 Earnings Insights
Shares of Nicolet Bankshares (NASDAQ:NCBS) fell in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased 38.28% over the past year to $1.77, which beat the estimate of $1.63.
Dover’s Return On Capital Employed Overview
Pulled from Benzinga Pro data, Dover (NYSE:DOV) posted Q3 earnings of $342.03 million, an increase from Q2 of 0.61%. Sales dropped to $2.02 billion, a 0.69% decrease between quarters.